{"DataElement":{"publicId":"6820016","version":"1","preferredName":"PALB2 Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the PALB2 gene mutation abnormality identified.","longName":"6819732v1.0:2556910v1.0","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6819732","version":"1","preferredName":"PALB2 Gene Mutation Abnormality Identification","preferredDefinition":"This gene may play a role in the repair of DNA damage that is resolved by recombination._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._The procedure of having an identity established.","longName":"6819730v1.0:6060068v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"6819730","version":"1","preferredName":"PALB2 Gene","preferredDefinition":"This gene may play a role in the repair of DNA damage that is resolved by recombination.","longName":"C84945","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PALB2 Gene","conceptCode":"C84945","definition":"This gene may play a role in the repair of DNA damage that is resolved by recombination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DF90832-EADC-3647-E053-F662850A6C89","latestVersionIndicator":"Yes","beginDate":"2019-07-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-18","modifiedBy":"ONEDATA","dateModified":"2019-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6060068","version":"1","preferredName":"Mutation Abnormality Identification","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.:The procedure of having an identity established.","longName":"C45576:C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647B3BCD-7CC7-0A68-E053-F662850A93B4","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DF90832-EAEA-3647-E053-F662850A6C89","latestVersionIndicator":"Yes","beginDate":"2019-07-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-18","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeDescription":"Created for Prostate Cancer request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2556910","version":"1","preferredName":"Specify","preferredDefinition":"Be specific about something; define clearly.","longName":"SPEC","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2390957","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"C25685","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FEED0CD5-44DE-6158-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-08-22","modifiedBy":"ONEDATA","dateModified":"2005-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"24FA6376-5316-2DE9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-12-19","modifiedBy":"REEVESD","dateModified":"2014-02-25","changeDescription":"10/20/08mn-added origin.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000016","version":"1","longName":"Prostate","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Specify PALB2 mutation","type":"Preferred Question Text","description":"Specify PALB2 mutation","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E45EED3-5256-08BB-E053-F662850A0499","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeDescription":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}